trial

The Effect of a Mindfulness-Based Self-Compassion Program on Care Burden, Life Satisfaction, and Coping Levels of Caregivers of Individuals With Schizophrenia

NCTId NCT06941909
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 44 (actual)
Sponsored by Neslihan Lok
Primary completion 2024-01-20
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
44 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-01-13
Primary completion
2024-01-20
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Mindfulness-Based Self-Compassion

Sponsors

Neslihan LokLead Sponsor

Investigators

1
Neslihan LÖK, Prof. Dr.Study Director

Sites

1 total
Konya, Turkey (Türkiye)

Facts & assertions

4 sourced
Enrollment
44
Phase
NA
Primary Completion Date
2024-01-20
Status
COMPLETED
relationships
The graph out of here
drug
Mindfulness-Based Self-Compassion
drug
lead_sponsor
Neslihan Lok
company
indication
Stress
indication
Satisfaction With Life
indication
Schizophrenia
indication
investigator
Neslihan LÖK, Prof. Dr.
person